OTCM
EWLU
Market cap6kUSD
Dec 15, Last price
0.00USD
Name
Merion Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Merion, Inc. operates as a provider of health and nutritional supplements, alongside personal care products, serving markets in both the United States and the People's Republic of China. Its diverse product lineup includes "Noir Naturel," a gentle hair treatment designed to cover grey from the initial application; the "Viwooba" series (1-3), natural aphrodisiac supplements formulated for men; "Lady-S," a dietary aid created to assist women with weight loss; "Gold King," a nutritional supplement offering antioxidant benefits and supporting liver health; "New Power," specifically developed to promote cardiac well-being; "Taibao," a supplement aimed at boosting physical performance and energy metabolism; and "ReMage Power," a nutritional product that aids anti-aging through Nicotinamide adenine dinucleotide (NAD+) support while also enhancing cellular energy and metabolism. The company distributes its products directly to consumers through its website, merionus.com, and also supplies wholesale distributors via phone and other electronic communication methods. Originally founded in 2007 as E-World USA Holding, Inc., the company adopted the name Merion, Inc. in June 2017. Its main office is located in West Covina, California.
Key people
Ding Wang
Chairman of the Board, President, Chief Executive Officer, Chief Financial Officer · since 2011
Vickie Ho
Executive Vice President · since 2017
Xun Zhang
Independent Director · since 2017
Legal address
C/O The Corporation Trust Company of Nevada
311 South Division Street
Carson City, NV 89703
US
311 South Division Street
Carson City, NV 89703
US
Headquarters
9550 Flair Drive
El Monte, CA 91731
US
El Monte, CA 91731
US
Valuation
Title in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | ||||||
Unusual Expense (Income) | ||||||
NOPBT | ||||||
NOPBT Margin | ||||||
Operating Taxes | ||||||
Tax Rate | ||||||
NOPAT | ||||||
Net income | ||||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | ||||||
BB yield | ||||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | ||||||
| Cash flow | ||||||
Cash from operating activities | ||||||
CAPEX | ||||||
Cash from investing activities | ||||||
Cash from financing activities | ||||||
FCF | ||||||
| Balance | ||||||
Cash | ||||||
Long term investments | ||||||
Excess cash | ||||||
Stockholders' equity | ||||||
Invested Capital | ||||||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | ||||||
Price | ||||||
Market cap | ||||||
EV | ||||||
EBITDA | ||||||
EV/EBITDA | ||||||
Interest | ||||||
Interest/NOPBT |